• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与采用谷氨酸脱氢酶/毒素两步法后再进行核酸扩增检测(NAAT)的算法相比,日本采用单一核酸扩增检测(NAAT)诊断途径的预算影响分析。

Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT.

作者信息

Lim Vanessa W, Tomaru Takeshi, Chua Brandon, Ma Yan, Yanagihara Katsunori

机构信息

Health Economics and Outcomes Research, Becton Dickinson Holdings Pte. Ltd., 2 International Business Park Road, Singapore 609930, Singapore.

Health Economics and Outcomes Research, Nippon Becton Dickinson Company, Ltd., Akasaka Garden City 15-1, Akasaka 4-Chome, Minato-ku, Tokyo 107-0052, Japan.

出版信息

Diagnostics (Basel). 2023 Apr 18;13(8):1463. doi: 10.3390/diagnostics13081463.

DOI:10.3390/diagnostics13081463
PMID:37189564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10137341/
Abstract

infection (CDI) is a major healthcare-associated infection that leads to a significant health economic burden in Japan. Using a decision tree model, we evaluated the budget impact of adopting a one-step nucleic acid amplification test (NAAT) alone pathway compared to a two-step diagnostic algorithm with glutamate dehydrogenase (GDH) and toxin antigen, followed by NAAT. The analysis was conducted from the government payer's perspective for 100,000 symptomatic, hospitalized adults requiring a CDI diagnostic test. One-way sensitivity analysis was conducted for all data inputs. The NAAT alone strategy costed JPY 225,886,360 (USD 2,424,714) more, but was more effective, resulting in 1749 more patients accurately diagnosed and 91 fewer deaths compared to the two-step algorithm. Additionally, the NAAT alone pathway costed JPY 26,146 (USD 281) less per true positive CDI diagnosed. The total budget impact, and cost per CDI diagnosed was most sensitive to GDH sensitivity in one-way sensitivity analysis, where a lower GDH sensitivity resulted in greater cost savings with the NAAT alone pathway. Findings from this budget impact analysis can guide the adoption of a NAAT alone pathway for CDI diagnosis in Japan.

摘要

艰难梭菌感染(CDI)是一种主要的医疗保健相关感染,在日本造成了巨大的健康经济负担。我们使用决策树模型,评估了与采用谷氨酸脱氢酶(GDH)和毒素抗原的两步诊断算法,随后进行核酸扩增试验(NAAT)相比,单独采用一步核酸扩增试验(NAAT)途径的预算影响。该分析是从政府支付方的角度,针对100,000名有症状的住院成年患者进行的,这些患者需要进行CDI诊断测试。对所有数据输入进行了单向敏感性分析。单独采用NAAT策略的成本高出225,886,360日元(2,424,714美元),但更有效,与两步算法相比,准确诊断的患者多1749例,死亡少91例。此外,单独采用NAAT途径每诊断出一例真正的阳性CDI成本降低26,146日元(281美元)。在单向敏感性分析中,总预算影响以及每例CDI诊断成本对GDH敏感性最为敏感,其中较低的GDH敏感性导致单独采用NAAT途径可节省更多成本。这项预算影响分析的结果可为日本采用单独的NAAT途径进行CDI诊断提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/736420f53b60/diagnostics-13-01463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/0ac9276de0d8/diagnostics-13-01463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/f2079e59501d/diagnostics-13-01463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/736420f53b60/diagnostics-13-01463-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/0ac9276de0d8/diagnostics-13-01463-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/f2079e59501d/diagnostics-13-01463-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c20d/10137341/736420f53b60/diagnostics-13-01463-g003.jpg

相似文献

1
Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT.与采用谷氨酸脱氢酶/毒素两步法后再进行核酸扩增检测(NAAT)的算法相比,日本采用单一核酸扩增检测(NAAT)诊断途径的预算影响分析。
Diagnostics (Basel). 2023 Apr 18;13(8):1463. doi: 10.3390/diagnostics13081463.
2
Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.艰难梭菌感染四种常见诊断方法的成本效益分析
J Gen Intern Med. 2020 Apr;35(4):1102-1110. doi: 10.1007/s11606-019-05487-5. Epub 2020 Feb 3.
3
Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.实验室检测用于检测艰难梭菌的性能:日本的一项多中心前瞻性研究。
Anaerobe. 2019 Dec;60:102107. doi: 10.1016/j.anaerobe.2019.102107. Epub 2019 Oct 21.
4
A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.发展中国家产毒艰难梭菌诊断算法的疾病成本比较。
Anaerobe. 2021 Aug;70:102390. doi: 10.1016/j.anaerobe.2021.102390. Epub 2021 May 28.
5
A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.两步算法结合谷氨酸脱氢酶和核酸扩增试验检测粪便标本中的艰难梭菌。
Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):345-351. doi: 10.1007/s10096-020-04027-y. Epub 2020 Sep 18.
6
Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection.比较不同方法诊断艰难梭菌感染的经济和健康效益。
Clin Microbiol Infect. 2015 Jan;21(1):77.e1-9. doi: 10.1016/j.cmi.2014.07.002. Epub 2014 Oct 29.
7
A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of () in Adults.一项关于核酸扩增检测(NAATs)和包括 NAATs 在内的算法在诊断成人()中的实验室医学最佳实践系统评价和荟萃分析。
Clin Microbiol Rev. 2019 May 29;32(3). doi: 10.1128/CMR.00032-18. Print 2019 Jun 19.
8
Impact of a division-wide bundle on cases, antibiotic days of therapy, testing appropriateness, and associated financial costs.全部门综合治疗方案对病例、抗生素治疗天数、检测适宜性及相关财务成本的影响。
Avicenna J Med. 2021 Jan 5;11(1):27-32. doi: 10.4103/ajm.ajm_193_19. eCollection 2021 Jan-Mar.
9
Potential underreporting of treated patients using a testing algorithm that screens with a nucleic acid amplification test.使用一种通过核酸扩增试验进行筛查的检测算法,可能会导致治疗患者的漏报。
Infect Control Hosp Epidemiol. 2024 May;45(5):590-598. doi: 10.1017/ice.2023.262. Epub 2024 Jan 25.
10
Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.核酸扩增检测的引入对威尔士艰难梭菌检测和核糖体型分布的影响。
Anaerobe. 2021 Feb;67:102313. doi: 10.1016/j.anaerobe.2020.102313. Epub 2020 Dec 9.

引用本文的文献

1
Rapid, Point-of-Care Microwave Lysis and Electrochemical Detection of Directly from Stool Samples.直接从粪便样本中进行快速即时微波裂解和电化学检测。
Bioengineering (Basel). 2024 Jun 20;11(6):632. doi: 10.3390/bioengineering11060632.
2
Experience with PCR Testing for Enteric Bacteria and Viruses of Emergency Department Patients with Acute Gastroenteritis: Are There Implications for the Early Treatment of Infection?急诊科急性胃肠炎患者肠道细菌和病毒的PCR检测经验:对感染的早期治疗有何启示?
Antibiotics (Basel). 2024 Mar 6;13(3):243. doi: 10.3390/antibiotics13030243.

本文引用的文献

1
A Bayesian method for synthesizing multiple diagnostic outcomes of COVID-19 tests.一种用于综合新型冠状病毒肺炎检测多种诊断结果的贝叶斯方法。
R Soc Open Sci. 2021 Sep 15;8(9):201867. doi: 10.1098/rsos.201867. eCollection 2021 Sep.
2
Economic burden and cost-effectiveness of therapies for infection: a narrative review.感染治疗的经济负担和成本效益:一项叙述性综述
Therap Adv Gastroenterol. 2021 May 30;14:17562848211018654. doi: 10.1177/17562848211018654. eCollection 2021.
3
Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan.
叙述性评论:日本政府扩大抗菌药物管理手册的过程。
Intern Med. 2021 Jan 15;60(2):181-190. doi: 10.2169/internalmedicine.4760-20. Epub 2020 Jul 21.
4
Open colectomy vs. laparoscopic colectomy in Japan: a retrospective study using real-world data from the diagnosis procedure combination database.日本开腹结肠切除术与腹腔镜结肠切除术的比较:一项基于诊断-操作组合数据库的真实世界回顾性研究。
Surg Today. 2020 Oct;50(10):1255-1261. doi: 10.1007/s00595-020-02006-6. Epub 2020 Apr 25.
5
Excess length of hospital stay, mortality and cost attributable to () infection and recurrence: a nationwide analysis in Japan.()感染和复发导致的住院时间延长、死亡率和费用:日本全国性分析。
Epidemiol Infect. 2020 Mar 2;148:e65. doi: 10.1017/S0950268820000606.
6
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.2008-2017 年日本医院艰难梭菌(梭状芽孢杆菌)感染:基于实际情况的全国范围内治疗模式、发病率和检测密度分析。
J Infect Chemother. 2020 May;26(5):438-443. doi: 10.1016/j.jiac.2019.11.005. Epub 2020 Feb 17.
7
Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.艰难梭菌感染四种常见诊断方法的成本效益分析
J Gen Intern Med. 2020 Apr;35(4):1102-1110. doi: 10.1007/s11606-019-05487-5. Epub 2020 Feb 3.
8
Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.使用索赔数据库评估日本复发性艰难梭菌感染的发生率和危险因素:一项回顾性队列研究。
Anaerobe. 2020 Feb;61:102139. doi: 10.1016/j.anaerobe.2019.102139. Epub 2019 Dec 10.
9
A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of () in Adults.一项关于核酸扩增检测(NAATs)和包括 NAATs 在内的算法在诊断成人()中的实验室医学最佳实践系统评价和荟萃分析。
Clin Microbiol Rev. 2019 May 29;32(3). doi: 10.1128/CMR.00032-18. Print 2019 Jun 19.
10
Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.艰难梭菌(梭状芽孢杆菌)感染负担在日本:一项多中心前瞻性研究。
Anaerobe. 2019 Dec;60:102011. doi: 10.1016/j.anaerobe.2019.03.007. Epub 2019 Mar 12.